Rise of Streptococcus pneumoniae isolates containing both erm(B) and mef(E) genes from an adult tertiary care community hospital system

Diagnostic Microbiology and Infectious Disease

Volumn 55, Issue 4, 2006, Pages 327-331

  DiPersio, Linda P ^a   DiPersio, Joseph R ^a   Beach, Jacqueline A ^a   DeFine, Linda A ^a  

^a SUMMA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLONE; COMMUNITY HOSPITAL; CONTROLLED STUDY; ERYTHROMYCIN RIBOSOME METHYLASE GENE; INFECTION RATE; MACROLIDE EFFLUX E GENE; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; STREPTOCOCCUS PNEUMONIAE; TERTIARY HEALTH CARE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CLINDAMYCIN; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HUMANS; MEMBRANE PROTEINS; METHYLTRANSFERASES; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 33746462696     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2006.01.030     Document Type: Article

References (29)

1. Bean D.C., and Klena J.D. Prevalence of erm(A) and mef(B) erythromycin resistance determinants in isolates of Streptococcus pneumoniae from New Zealand. J. Antimicrob. Chemother. 50 (2002) 597-599
2. Brown S.D., and Farrell D.J. Antibacterial susceptibility among Streptococcus pneumoniae isolated from paediatric and adult patients as part of the PROTEKT US study in 2001-2001. J. Antimicrob. Chemother. 54 Suppl S1 (2004) i23-i29
3. Corso A., Severina E.P., Petruk V.F., Mauriz Y.R., and Tomasz A. Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates causing respiratory disease in the United States. Microb. Drug Resis. 4 (1998) 325-337
4. Daly M.M., Doktor S., Flamm R., and Shortridge D. Characterization and prevalence of MefA, MefE, and the associated gene msr(D) gene in Streptococcus pneumoniae clinical isolates. J. Clin. Microbiol. 42 (2004) 3570-3574
5. Del Grosso M., Iannelli F., Messina C., Santagati M., Petrosillo N., Stefani S., Pozzi G., and Pantosti A. Macrolide efflux genes mef(A) and mef(E) are carried by different genetic elements in Streptococcus pneumoniae. J. Clin. Microbiol. 40 (2002) 774-778
6. DiPersio J.R., Files Jr. T.M., Stevens D.L., Gardner W.G., Petropoulos G., and Dinsa K. Spread of serious disease-producing M3 clones of group A Streptococcus among family members and health care workers. Clin. Infect. Dis. 22 (1996) 490-495
7. Doern G.V., Brueggemann A.B., Huynh H., Wingert E., and Rhomberg P. Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997-98. Emerg. Infect. Dis. 5 (1999) 757-765
8. Farrell D.J., and Jenkins S.G. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 201-202. J. Antimicrob. Chemother. 54 Suppl S1 (2004) i17-i22
9. Farrell D.J., Douthwaite S., Morrissey I., Bakker S., Poehlsgaard J., Jakobsen L., and Felmingham D. Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study. Antimicrob. Agents Chemother. 47 (2003) 1777-1783
10. Farrell D.J., Jenkins S.G., Brown S.D., Patel M., Lavin B.S., and Klugman K.P. Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance. Emerg. Infect. Dis. 11 (2005) 851-858
11. Felmingham D., Reinert R.R., Hirakata Y., and Rodloff A. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and comparative in vitro activity of the ketolide, telithromycin. J. Antimicrob. Chemother. 50 Suppl S1 (2002) 25-37
12. Hoban D.J., Wierzbowski A.K., Nichol K., and Zhanel G.G. Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides. Antimicrob. Agents Chemother. 45 (2001) 2147-2150
13. Johnston N.J., De Azavedo J.C., Kellner J.D., and Low D.E. Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42 (1998) 2425-2426
14. Klugman K.P., Capper T., Widdowson C.A., Koornhof H.J., and Moser W. Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: characterization of South African isolates. J. Antimicrob. Chemother. 42 (1998) 729-734
15. Louie L., Goodfellow J., Mathieu P., Glatt A., Louie M., and Simor A.E. Rapid detection of methicillin-resistant staphylococci from blood culture bottles by using a multiplex PCR assay. J. Clin. Microbiol. 40 (2002) 2786-2790
16. McGee L., Klugman K.P., Wasas A., Capper T., Brink A., and and the Antibiotics Surveillance Forum of South Africa. Serotype 19F multiresistant pneumococcal clone harboring two erythromycin resistance determinants [erm(B) and mef(A)] in South Africa. Antimicrob. Agents Chemother. 45 (2001) 1595-1598
17. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial susceptibility testing; fourteenth informational supplement, M100-S14 (2004), National Committee for Clinical Laboratory Standards, Wayne, PA
18. Nishijima T., Saito Y., Aoki A., Toriya M., Toyonaga Y., and Fujii R. Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics. J. Antimicrob. Chemother. 43 (1999) 637-643
19. Oster P., Zanchi A., Cresti S., Lattanzi M., Montagnani F., Cellesi C., and Rossolini G.M. Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates. Antimicrob. Agents Chemother. 43 (1999) 2510-2512
20. Poyart C., Jardy L., Quesne G., Berche P., and Trieu-Cuot P. Genetic basis of antibiotic resistance in Streptococcus agalactiae strains isolated in a French hospital. Antimicrob. Agents Chemother. 47 (2003) 794-797
21. Roberts M.C., Sutcliffe J., Courvalin P., Jensen L.B., Rood J., and Seppala H. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob. Agents Chemother. 43 (1999) 2823-2830
22. Shortridge V.D., Doern G.V., Brueggemann A.B., Beyer J.M., and Flamm R.K. Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995. Clin. Infect. Dis. 29 (1999) 1186-1188
23. Song J.-H., Chang H.-H., Suh J.Y., Ko K.S., Jung S.-I., Oh W.S., Peck K.R., Lee N.Y., Yang Y., Chongthaleong A., Aswapokee N., Chiu C.-H., Lalitha M.K., Perera J., Yee T.T., Kumararasinghe G., Jamal F., Kamarulazaman A., Parasakthi N., Van P.H., So T., Ng T.K., and on behalf of the ANSORP Study Group. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP). J. Antimicrob. Chemother. 53 (2004) 457-463
24. Sutcliffe J., Grebe T., Tait-Kamradt A., and Wondrack L. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40 (1996) 2562-2566
25. Toltzis P., Dul M., O'riordan M.A., Jacobs M.R., and Blumer J. Serogroup 19 pneumococci containing both mef and erm macrolide resistance determinants in an American city. Pediatr. Infect. Dis. J. 25 (2006) 19-24
26. Waites K.B., Jones K.E., Kim K.H., Moser S.A., Johnson C.N., Hollingshead S.K., Kang E.-S., Hong K.S., and Benjamin Jr. W.H. Dissemination of macrolide-resistant Streptococcus pneumoniae isolates containing both erm(B) and mef(A) in South Korea. J. Clin. Microbiol. 41 (2003) 5787-5791
27. Weis K., Guilbault C., Cortes L., Restieri C., Low D.E., and and the EQUERE project. Genotypic characterization of macrolide-resistant strains of Streptococcus pneumoniae isolated in Quebec, Canada, and in vitro activity of ABT-773 and telithromycin. J. Antimicrob. Chemother. 50 (2002) 403-406
28. Zhanel G.G., Palatnick L., Nichol K.A., Bellyou T., Low D.E., and Hoban D.J. Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002. Antimicrob. Agents Chemother. 47 (2003) 1867-1874
29. Zolezzi P.C., Laplana L.M., Calvo C.R., Cepero P.G., Erazo M.C., and Gomez-Lus R. Molecular basis of resistance to macrolides and other antibiotics in commensal viridans group streptococci and Gemella spp. and transfer of resistance genes to Streptococcus pneumoniae. Antimicrob. Agents Chemother. 48 (2004) 3462-3467